In August 2021, the U.S. Food and Drug Administration (FDA) announced a recall of a variety of Exactech knee and ankle replacements with polyethylene components and inserts, due to risk of device failure that could lead to health risks and require corrective revision surgery.
In February 2022, Exactech, a company that manufactures knee and ankle replacement devices, issued a recall for their Optetrak, Truliant, and Vantage products after reports from consumers that the plastic inserts are defective, causing an elevated risk of device failure and health complications. According to the recall, their products were stored in vacuum-sealed bags that allowed oxygen to diffuse into the devices and warp them during storage and before being implanted in a patient. The defect significantly increases the risk of future knee problems, and with over 147,000 knee implants performed since 2004, there are too many individuals who have undergone severe hardship because a negligent organization failed to ensure that their products were safe before arriving at consumers as the opposite.
Generally speaking, patients who received defective Exactech knee replacement devices have four years to file a lawsuit against the company. This limitations period runs from the date that patients learned, or reasonably should have learned, that they had a claim against the company for a defective medical device. If you or a loved one have undergone a total knee replacement since 2004 that may have involved an Exactech Optetrak, Exactech Optetrak Logic, or Exactech Truliant knee implant, financial compensation, and settlement benefits may be available. Additionally, it is not necessary that you know whether a recalled Extactech knee implant was used before contacting us to investigate further.
Contact Consumer Coalition today for your free, confidential claim review.
